Susan Greenfield
| The Baroness Greenfield | |||
|---|---|---|---|
 |
|||
| Born | Susan Adele Greenfield 1 October 1950 Hammersmith, London, England, UK |
||
| Nationality | British | ||
| Institutions | |||
| Alma mater | St Hilda's College, Oxford | ||
| Thesis | Origins of acetylcholinesterase in cerebrospinal fluid (1977) | ||
| Doctoral advisor | Anthony David Smith | ||
| Notable awards | Chevalier Légion d'honneur | ||
| Spouse | Peter Atkins (m. 1991–2005) | ||
|
Website www |
|||
|
|||
Susan Adele Greenfield, Baroness Greenfield CBE FRCP (born 1 October 1950) is a British scientist, writer, broadcaster, and member of the House of Lords. Her research has focused on the treatment of Parkinson's disease and Alzheimer's disease. She is also interested in the neuroscience of consciousness and the impact of technology on the brain.
Greenfield is Senior Research Fellow at Lincoln College, Oxford University and was Professor of Synaptic Pharmacology.
She was also Chancellor of Heriot-Watt University in Edinburgh between 2005 and 2013. From 1998 to 2010, she was director of the Royal Institution of Great Britain. In September 2013, she co-founded the biotech company Neuro-bio Ltd, where she is Chief Executive Officer.
Susan Adele Greenfield was born to a Jewish father and a Christian mother in Hammersmith, London. Her mother, Doris (née Thorp), was a dancer, and her father, Reginald Myer Greenfield, was an electrician.
She attended the Godolphin and Latymer School, where she took A levels in Latin, Greek and ancient history, and maths. The first member of her immediate family to go to university, she was initially admitted to St Hilda's College to read Philosophy and Psychology, but changed course and graduated with a first-class degree in experimental psychology. As a Senior Scholar at St Hugh's College, Oxford, she completed her DPhil degree in 1977 under the supervision of Anthony David Smith on the Origins of acetylcholinesterase in cerebrospinal fluid.
...
Wikipedia